MCFD2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.945400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.543200E-01
Normal-vs-Stage2
5.816400E-01
Normal-vs-Stage3
3.941200E-01
Normal-vs-Stage4
2.485200E-01
Stage1-vs-Stage2
7.733800E-01
Stage1-vs-Stage3
9.873900E-02
Stage1-vs-Stage4
3.538400E-01
Stage2-vs-Stage3
2.021600E-01
Stage2-vs-Stage4
7.255600E-01
Stage3-vs-Stage4
4.585900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.701600E-01
Normal-vs-AfricanAmerican
4.600800E-01
Normal-vs-Asian
4.123600E-01
Caucasian-vs-AfricanAmerican
4.240000E-01
Caucasian-vs-Asian
2.554400E-02
AfricanAmerican-vs-Asian
1.391640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.311000E-01
Normal-vs-Female
5.292600E-01
Male-vs-Female
9.888000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.316200E-01
Normal-vs-Age(41-60Yrs)
2.329600E-01
Normal-vs-Age(61-80Yrs)
8.079800E-01
Normal-vs-Age(81-100Yrs)
8.085800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.580800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.713400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.905200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.359500E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.064440E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.244800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.400400E-01
Normal-vs-Daily Drinker
9.524000E-01
Normal-vs-Weekly Drinker
9.457000E-01
Normal-vs-Occasional Drinker
4.339400E-01
Normal-vs-Social Drinker
5.282600E-01
Non Drinker-vs-Daily Drinker
9.851600E-01
Non Drinker-vs-Weekly Drinker
9.961600E-01
Non Drinker-vs-Occasional Drinker
1.002790E-01
Non Drinker-vs-Social Drinker
2.232400E-01
Daily Drinker-vs-Weekly Drinker
9.916600E-01
Daily Drinker-vs-Occasional Drinker
1.470350E-01
Daily Drinker-vs-Social Drinker
2.763000E-01
Weekly Drinker-vs-Occasional Drinker
1.641170E-01
Weekly Drinker-vs-Social Drinker
2.817800E-01
Occasional Drinker-vs-Social Drinker
7.722800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.929600E-01
Normal-vs-Grade 2
1.674410E-01
Normal-vs-Grade 3
1.530010E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.118800E-01
Grade 1-vs-Grade 3
3.311700E-02
Grade 1-vs-Grade 4
4.929600E-01
Grade 2-vs-Grade 3
1.795350E-01
Grade 2-vs-Grade 4
1.674410E-01
Grade 3-vs-Grade 4
1.530010E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.882000E-01
Normal-vs-NonDiabetic
6.898800E-01
Diabetic-vs-NonDiabetic
9.493800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.633000E-01
Normal-vs-NoPancreatitis
6.473200E-01
Pancreatitis-vs-NoPancreatitis
7.360600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.162200E-01
Normal-vs-N1
5.426000E-01
N0-vs-N1
4.352600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.026600E-01
Normal-vs-TP53-NonMutant
7.484200E-01
TP53-Mutant-vs-TP53-NonMutant
3.821700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
